Inventor
CATHERS BRIAN E
US12 patents
Patents
12 patentsUS9499514B2Nov 22, 2016
Antiproliferative compounds and methods of use thereof
CELGENE CORP28 citations93
US10357489B2Jul 23, 2019
Antiproliferative compounds and methods of use thereof
CELGENE CORP20 citations92
US11185543B2Nov 30, 2021
Antiproliferative compounds and methods of use thereof
CELGENE CORP5 citations82
US10092555B2Oct 9, 2018
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
CELGENE CORP8 citations82
US9968596B2May 15, 2018
Antiproliferative compounds and methods of use thereof
CELGENE CORP8 citations82
US9808451B2Nov 7, 2017
Antiproliferative compounds and methods of use thereof
CELGENE CORP12 citations82
US11241423B2Feb 8, 2022
Antiproliferative compounds and methods of use thereof
CELGENE CORP2 citations72
US11419861B2Aug 23, 2022
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
CELGENE CORP1 citations71
US10668057B2Jun 2, 2020
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
CELGENE CORP3 citations71
US11733233B2Aug 22, 2023
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
CELGENE CORP0 citations61
US10830762B2Nov 10, 2020
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
CELGENE CORP1 citations61
US12029738B2Jul 9, 2024
Antiproliferative compounds and methods of use thereof
CELGENE CORP0 citations59